Pain Warriors Unite - (202) 792-5600
This Website was built by pain patients FOR pain patients, advocates, group leaders, health care professionals, and anyone else who wants to join in our collective cause to fight for the right to receive fair and equitable PAIN MANAGEMENT.
Please Click Below for Official Press Release
It's CRUCIAL for all CPP'S to CALL to Schedule a meeting or attend local events to discuss the implementation of our National Pain Policy.
Send them the link to the HHS Pain Task Force's Report here:
Please use our handy Legislative Outreach Kit & ask for assistance if necessary. The only way to change the current pathway which has created a hostile regulatory environment is to GET INVOLVED IN THE LEGISLATIVE PROCESS ASAP
CLICK HERE TO LOCATE YOUR STATE & FEDERAL REPRESENTATIVES
What can YOU do to help?
If you need help, please let us know & we'll be happy to provide the information you'll need!
As the country grapples with the opioid epidemic, there's been a broad crackdown on opioids in general. Now, HHS is urging doctors not to go too far in cutting off prescriptions. Other news on the crisis focuses on the court challenges to Purdue Pharma and other drugmakers.
HHS' assistant secretary for health Dr. Brett Giroir urged clinicians to collaborate with patients on deciding how fast they reduce or stop their opioid therapies.
"We know that it is critical that clinicians manage acute and chronic pain in an individualized, patient-centered way," Giroir said.
There have been numerous reports of individuals being abruptly cut off their medication regimen after the Centers for Disease Control and Prevention's Guideline for Prescribing Opioids for Chronic Pain in 2016, according to Giroir.
The CDC guidelines recommended clinicians prescribe opioids only after exhausting other pain therapies, prescribe the lowest effective dosage, evaluate patients within 1 to 4 weeks of starting opioid therapy for chronic pain, and taper or discontinue opioids if the harms OUTWEIGH the benefits.
"Clearly, we believe that there has been a misinterpretation of the [CDC] guidelines, which were very clear," Giroir said. "People have inappropriately misinterpreted cautionary dosage thresholds as mandates for dose reduction."
RE: Overview of Pain Management Task Force Meeting & Recommendations
View Task Force's Final Report HERE
The purpose of this final meeting was for the Task Force members to disseminate and discuss the final report in full detail. They debated and deliberated to carefully refine the language and terminology to avoid future misinterpretation or misapplication. They reviewed the consensus of thousands of comments submitted by the public during the previous public comment
Use the MedWatch form to report adverse events that you observe or suspect for human medical products, including serious drug side effects, product use/medication error, product quality problems, and therapeutic failures for:
Find a Pain Specialist:
Tips for Finding a Pain Specialist HERE: https://paindoctor.com/pain-management-doctors/
Tools for Patients: https://www.painscale.com
Search for pain management doctors from the following sources:
Find Upcoming Events in Your State:
** URGENT BULLETIN ** Please SHARE with all State& Federal Representatives and Regulatory Agencies in charge of regulating Controlled Substances/Opioid prescribing.
Re: CDC Guideline Clarification Letter & FDA Advisory Notice pertaining to Opioid Prescribing
Below is a letter from the CDC clarifying the 2016 Opioid Prescribing Guideline and an Advisory Notice issued by the FDA regarding abrupt opioid tapering.
The Guideline is not intended to deny any patients who suffer with chronic pain from receiving opioid therapy as an option for pain management. Rather, the Guideline is intended to ensure that clinicians and patients consider all safe and effective treatment options for patients.
Clinical decision-making should be based on the relationship between the clinician and patient, with an understanding of the patient’s clinical situation, functioning, and life context, as well as a careful consideration of the benefits and risk of all treatment options, including opioid therapy.
CDC encourages physicians to continue to use their clinical judgment and base treatment on what they know about their patients, includes the use of opioids if determined to be the best course of treatment. Providers should communicate frequently with their patients to discuss both the benefits and risks of opioid therapy and revisit treatment plans for pain regularly to achieve the most positive outcomes for patients.
Reports of "serious harm" in patients dependent on opioid painkillerswho suddenly stop taking the medication, or rapidly decrease the dose, have prompted a drug safety communication issued today by the US Food and Drug Administration (FDA).
April 26th report by Shepard Smith about the harms to chronic pain patients as a result of the overarching CDC Guidelines.
Link to Video: https://youtu.be/2Jg0ZV9ftFE
Fox News' Greg Gutfeld has been reporting about our plight for several months. Watch the most recent segment about the CDC Clarification featured on "The Five"
Watch segment here:
Former Drug Czar Dr. William Bennett: "the problem isn't rx drugs...talk to the coroner's, I have. It's Fentanyl & meth that's the major cause of death today."
Jennifer Braceras, Esq. vs Dr. Mark Siegel discuss the Opioid Trial Verdict:
Did the government overcorrect on the opioid epidemic?
Jun. 26, 2019 - CDC guidelines have led to doctors cutting back on painkiller subscriptions, leaving patients fighting to get the medication they need.
Fox News’ Dagen Mcdowell's Mom suffering from bone CANCER has to fight with her doctor to receive pain medication.
WATCH ️ https://youtu.be/dQx3ycdmSFM
More from Greg Gutfeld:
On Gillibrand Opioid Crackdown:
Facts and Fallacies:
Dr. Drew: https://drdrew.com/tag/greg-gutfeld/
Daniel Horowitz, Esq. - The government’s war on pain patients
Dr. Bill Bennett:
Dr. Sally Satel
The U.S. Department of Health and Human Services Office for Civil Rights has released new guidance explaining when HIPAA permits health care providers and other covered entities to share a patient’s health information with loved ones and others involved in a patient’s care in these situations.
The guidance explains:
** PRESS RELEASE**
FOR IMMEDIATE RELEASE APRIL 10, 2019
TWO FEDERAL AGENCIES SPEAK AGAINST MANDATED OR PRECIPITOUS OPIOID REDUCTIONS IN CHRONIC PAIN PATIENTS
On April 10, the Director for the Centers for Disease Control and Prevention, Dr. Robert Redfield, wrote to Health Professionals for Patients in Pain (HP3) to state that the CDC’s 2016 Guideline offered no support for mandatory opioid dose reductions in patients with long-term pain. Coming on the heels of an April 9 warning from the United States Food and Drug Administration of “serious harm” to patients after rapid dose reduction or discontinuation, the Director’s letter flags the need for a recalibration of care decisions imposed by a wide range of private and governmental agencies that have invoked the CDC to justify coverage restrictions, quality metrics, legal threats and other actions to force dose reductions on nonconsenting patients.
Please CLICK BELOW to read Press Release & Access the CDC Director's Letter responding to the HP3 Letter
Sign up to Stay up to Date on the Latest News, Alerts, Deadlines, Calls to Action & Events Happening in the Pain Community.